Literature DB >> 20376579

Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity.

Dae-Sung Kim1, Jae Souk Lee, Joong Woo Leem, Yong Jun Huh, Ji Young Kim, Han-Soo Kim, In-Hyun Park, George Q Daley, Dong-Youn Hwang, Dong-Wook Kim.   

Abstract

Our analyses of three human induced pluripotent stem cell (hiPSC) and six human embryonic stem cell (hESC) lines showed marked variability in differentiation potential into specific lineages, which often hampers their differentiation into specific cell types or cell lineages of interest. Simultaneous inhibition of both Activin/Nodal and BMP pathways with small molecules, SB431542 and dorsomorphin (DM), respectively, promoted significant neural differentiation from all human pluripotent stem cell (hPSC) lines tested, regardless of their differentiation propensity. On the contrary, differentiation into other cell lineages and the number of undifferentiated cells were significantly reduced after differentiation by the dual inhibition. These results demonstrate that innate differentiation propensity of hPSCs could be overcome, at least in part, by modulation of intracellular signaling pathways, resulting in efficient generation of desirable cell types, such as neural cells.

Entities:  

Mesh:

Year:  2010        PMID: 20376579     DOI: 10.1007/s12015-010-9138-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  25 in total

Review 1.  Neural induction, the default model and embryonic stem cells.

Authors:  Ignacio Muñoz-Sanjuán; Ali H Brivanlou
Journal:  Nat Rev Neurosci       Date:  2002-04       Impact factor: 34.870

2.  Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers.

Authors:  Gillian M Beattie; Ana D Lopez; Nathan Bucay; Andrew Hinton; Meri T Firpo; Charles C King; Alberto Hayek
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

3.  Marked differences in differentiation propensity among human embryonic stem cell lines.

Authors:  Kenji Osafune; Leslie Caron; Malgorzata Borowiak; Rita J Martinez; Claire S Fitz-Gerald; Yasunori Sato; Chad A Cowan; Kenneth R Chien; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

4.  Derivation of neural precursors from human embryonic stem cells in the presence of noggin.

Authors:  Pavel Itsykson; Nili Ilouz; Tikva Turetsky; Ronald S Goldstein; Martin F Pera; Ianai Fishbein; Menahem Segal; Benjamin E Reubinoff
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

5.  Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells.

Authors:  Lei Xiao; Xuan Yuan; Saul J Sharkis
Journal:  Stem Cells       Date:  2006-02-02       Impact factor: 6.277

6.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.

Authors:  Daylon James; Ariel J Levine; Daniel Besser; Ali Hemmati-Brivanlou
Journal:  Development       Date:  2005-02-09       Impact factor: 6.868

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.

Authors:  Paul B Yu; Charles C Hong; Chetana Sachidanandan; Jodie L Babitt; Donna Y Deng; Stefan A Hoyng; Herbert Y Lin; Kenneth D Bloch; Randall T Peterson
Journal:  Nat Chem Biol       Date:  2007-11-18       Impact factor: 15.040

9.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  102 in total

1.  Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.

Authors:  Samira Asgari; Mohsen Moslem; Kamran Bagheri-Lankarani; Behshad Pournasr; Maryam Miryounesi; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 2.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 3.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

Review 4.  Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Authors:  Rebekah L Gundry; Paul W Burridge; Kenneth R Boheler
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

5.  Stem cell research and clinical development in tendon repair.

Authors:  Paola Filomeno; Victor Dayan; Cristina Touriño
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

6.  Naive-like conversion overcomes the limited differentiation capacity of induced pluripotent stem cells.

Authors:  Arata Honda; Masanori Hatori; Michiko Hirose; Chizumi Honda; Haruna Izu; Kimiko Inoue; Ryutaro Hirasawa; Shogo Matoba; Sumie Togayachi; Hiroyuki Miyoshi; Atsuo Ogura
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

Review 7.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

8.  Investigating synapse formation and function using human pluripotent stem cell-derived neurons.

Authors:  Ji-Eun Kim; Matthew L O'Sullivan; Christopher A Sanchez; Minju Hwang; Mason A Israel; Kristen Brennand; Thomas J Deerinck; Lawrence S B Goldstein; Fred H Gage; Mark H Ellisman; Anirvan Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-28       Impact factor: 11.205

Review 9.  Turning straw into gold: directing cell fate for regenerative medicine.

Authors:  Dena E Cohen; Douglas Melton
Journal:  Nat Rev Genet       Date:  2011-03-09       Impact factor: 53.242

10.  Activin/Smad2-induced Histone H3 Lys-27 Trimethylation (H3K27me3) Reduction Is Crucial to Initiate Mesendoderm Differentiation of Human Embryonic Stem Cells.

Authors:  Lu Wang; Xuanhao Xu; Yaqiang Cao; Zhongwei Li; Hao Cheng; Gaoyang Zhu; Fuyu Duan; Jie Na; Jing-Dong J Han; Ye-Guang Chen
Journal:  J Biol Chem       Date:  2016-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.